All Pharma News
Axsome Highlights Neuroscience Portfolio At AAN 2024

Axsome Highlights Neuroscience Portfolio At AAN 2024
GLOBENEWSWIRE
15 Apr 2024
Share Share
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
GLOBENEWSWIRE
10 Apr 2024
Share Share
Axsome Initiates Ph 3 Trial of Solriamfetol for Binge Eating Disorder

Axsome Initiates Ph 3 Trial of Solriamfetol for Binge Eating Disorder
GLOBENEWSWIRE
01 Apr 2024
Share Share
Axsome drug succeeds in narcolepsy symptoms trial

Axsome drug succeeds in narcolepsy symptoms trial
Jacob Bell BIOPHARMADIVE
26 Mar 2024
Share Share
Axsome Announces Results of CRESCENDO Narcolepsy Patient Survey

Axsome Announces Results of CRESCENDO Narcolepsy Patient Survey
GLOBENEWSWIRE
25 Mar 2024
Share Share
Axsome Initiates PARADIGM Ph3 Trial of Solriamfetol for the Treatment MDD

Axsome Initiates PARADIGM Ph3 Trial of Solriamfetol for the Treatment MDD
GLOBENEWSWIRE
19 Mar 2024
Share Share
Axsome Therapeutics to Present at Leerink Partners Global Biopharma Conference

Axsome Therapeutics to Present at Leerink Partners Global Biopharma Conference
GLOBENEWSWIRE
05 Mar 2024
Share Share
Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
GLOBENEWSWIRE
27 Feb 2024
Share Share
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
20 Feb 2024
Share Share
Axsome Tumbles On An Unexpected Setback For Its Alzheimer`s Drug

Axsome Tumbles On An Unexpected Setback For Its Alzheimer`s Drug
PRESS RELEASE
01 Feb 2024
Share Share